GYRE
Financials
- Market Capitalization 615.16 M
- Employee 618
- Founded 1997
- CEO N/A
- Website www.gyretx.com
- Headquarter Delaware, United States
- FIGI BBG000F88SY8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2771 |  MDXG MiMedx Group, Inc - Common Stock | 4.20 USD | +2.94% | +1.20% | +14.13% | -33.65% | 625.57 M USD | ||
| 2778 |  NGNE Neurogene Inc. - Common Stock | 39.08 USD | +1.98% | +6.37% | +30.27% | +32.83% | 617.54 M USD | ||
| 2786 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 11.70 USD | +3.54% | -4.88% | +27.31% | +3.54% | 611.63 M USD | ||
| 2800 |  FBRX Forte Biosciences, Inc. - Common Stock | 43.20 USD | -2.09% | +96.45% | +139.34% | +47.19% | 599.86 M USD |
Frequently asked questions about Gyre Therapeutics, Inc. - Common Stock
What is the Gyre Therapeutics, Inc. - Common Stock stock price today?
The current price of Gyre Therapeutics, Inc. - Common Stock (GYRE) is 6.34. Over the past 24 hours, the stock has changed by 0.00%. Follow the GYRE chart for real-time price dynamics.
What is the stock ticker of Gyre Therapeutics, Inc. - Common Stock?
Gyre Therapeutics, Inc. - Common Stock trades under the ticker GYRE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Gyre Therapeutics, Inc. - Common Stock stock going up?
GYRE has changed by -7.17% over the last week, +8.93% over the last month, and -23.24% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Gyre Therapeutics, Inc. - Common Stock release financial reports?
Yes. You can track Gyre Therapeutics, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Gyre Therapeutics, Inc. - Common Stock net income for the last quarter?
Gyre Therapeutics, Inc. - Common Stock reported net income of -9.86 M for the last quarter. The previous quarter showed -1.37 M, which means net income changed by -621.67%.
How many employees does Gyre Therapeutics, Inc. - Common Stock have?
As of the latest available data, Gyre Therapeutics, Inc. - Common Stock has 618 employees. Workforce size can provide additional context about the company's scale and operations.
What is Gyre Therapeutics, Inc. - Common Stock EBITDA?
Gyre Therapeutics, Inc. - Common Stock EBITDA is -8.68 M, and its EBITDA margin is -38.56%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Gyre Therapeutics, Inc. - Common Stock stock?
You can buy Gyre Therapeutics, Inc. - Common Stock (GYRE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Gyre Therapeutics, Inc. - Common Stock stock?
Investing in Gyre Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GYRE chart and related analysis on metatrader.com as part of your research.